Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions

SARS-CoV-2 infection was announced as a pandemic in March 2020. Since then, several scientists have focused on the low prevalence of smokers among hospitalized COVID-19 patients. These findings led to our hypothesis that the Nicotinic Cholinergic System (NCS) plays a crucial role in the manifestatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Toxicol Rep
Päätekijät: Alexandris, Nikolaos, Lagoumintzis, George, Chasapis, Christos T., Leonidas, Demetres D., Papadopoulos, Georgios E., Tzartos, Socrates J., Tsatsakis, Aristidis, Eliopoulos, Elias, Poulas, Konstantinos, Farsalinos, Konstantinos
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Regular Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776751/
https://ncbi.nlm.nih.gov/pubmed/33425684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2020.12.013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia